• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form EFFECT filed by Sio Gene Therapies Inc.

    4/25/23 12:15:08 AM ET
    $SIOX
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Get the next $SIOX alert in real time by email
    Notice of Effectiveness
    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549
    Notice of Effectiveness
    Effectiveness Date: April 24, 2023
    Accession Number: 0001636050-23-000026
    Submission Type: POS AM
    CIK: 0001636050
    Company Name: Sio Gene Therapies Inc.
    File Number: 333-235889
    Get the next $SIOX alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $SIOX

    DatePrice TargetRatingAnalyst
    2/1/2022$10.00 → $7.00Buy
    HC Wainwright & Co.
    2/1/2022$6.00 → $1.00Outperform → Market Perform
    SVB Leerink
    10/21/2021$8.00 → $10.00Buy
    HC Wainwright & Co.
    8/12/2021$7.00 → $6.00Outperform
    SVB Leerink
    7/12/2021$12.50Buy
    Chardan Capital Markets
    More analyst ratings